amodiaquine hydrochloride has been researched along with Malaria, Falciparum in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adjei, GO; Alifrangis, M; Goka, BQ; Hoegberg, LC; Kristensen, K; Kurtzhals, JA; Rodrigues, OP | 1 |
| Angulo-Barturen, I; Avery, VM; Bathurst, I; Bouck, D; Castro, S; Clark, J; Connelly, M; Crowther, GJ; Davis, PH; Derisi, JL; Duffy, S; El Mazouni, F; Ferrer, S; Forquer, I; Fowble, JW; Guiguemde, WA; Gut, J; Guy, RK; Jiménez-Díaz, MB; Lazo, JS; Martinez, MS; McGinley, PL; Phillips, MA; Rathod, PK; Riscoe, MK; Roos, DS; Rosenthal, PJ; Sharlow, ER; Shelat, AA; Smithson, DC; Sullivan, DJ; Tripathi, AK; Van Voorhis, WC; Wilson, EB; Zhu, F | 1 |
| Clark, JA; Connelly, MC; El Mazouni, F; Furimsky, A; Gow, J; Guiguemde, WA; Guy, RK; Iyer, L; Kyle, DE; Min, J; Mirsalis, J; Parman, T; Phillips, MA; Pradhan, A; Zhang, Y; Zhu, F | 1 |
| de Dios, A; Gorka, AP; Roepe, PD | 1 |
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
| Boesche, M; Crowther, GJ; Dasari, KS; Drewes, G; El Bakkouri, M; Fox, AM; Ghidelli-Disse, S; He, P; Hillesland, HK; Hui, R; Jones, JC; Keyloun, KR; Krahn, MM; Lafuente-Monasterio, MJ; Leonard, SE; Leroy, D; Maly, DJ; Mo, JS; Ojo, KK; Reid, MC; Rivas, KL; Van Voorhis, WC | 1 |
2 review(s) available for amodiaquine hydrochloride and Malaria, Falciparum
| Article | Year |
|---|---|
Quinoline drug-heme interactions and implications for antimalarial cytostatic versus cytocidal activities.
Topics: Antimalarials; Crystallization; Drug Resistance; Heme; Hemeproteins; Humans; Malaria, Falciparum; Molecular Structure; Plasmodium falciparum; Quinolines | 2013 |
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
1 trial(s) available for amodiaquine hydrochloride and Malaria, Falciparum
| Article | Year |
|---|---|
Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Child; Child, Preschool; Cytochrome P-450 CYP2C8; Drug Therapy, Combination; Female; Ghana; Humans; Malaria, Falciparum; Male; Polymorphism, Genetic; Treatment Outcome | 2008 |
3 other study(ies) available for amodiaquine hydrochloride and Malaria, Falciparum
| Article | Year |
|---|---|
Chemical genetics of Plasmodium falciparum.
Topics: Animals; Antimalarials; Cell Line; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Erythrocytes; Humans; Malaria, Falciparum; Mice; Phenotype; Phylogeny; Plasmodium falciparum; Reproducibility of Results; Small Molecule Libraries | 2010 |
Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.
Topics: Administration, Oral; Animals; Antimalarials; Biological Availability; Female; Hep G2 Cells; Humans; Malaria, Falciparum; Mice; Mice, Inbred ICR; Nuclear Magnetic Resonance, Biomolecular; Parasitemia; Plasmodium falciparum; Quinolines; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship | 2012 |
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
Topics: Antimalarials; Calcium; Cell Line, Tumor; Hep G2 Cells; Humans; Malaria, Falciparum; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Plasmodium falciparum; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protozoan Proteins | 2016 |